Supplier sign in
Home
STAY INFORMED
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.

     

COMPANY PAGE

Login
Latest update: 04-02-2020
Maxus Media
TEL: +31 297 22 34 62
FAX: +31
Marktplein 2
1421AC   Uithoorn
Contact
+31 6 2059 2436
Mr. Vincent Hentzepeter
Editor
+31 6 1003 1781
Mr. Erik ten Haaf
Sales manager

About labinsights.NET

LABinsights.net is a multimedia platform for the international lab industry. This platform includes a web portal and a digital newsletter. Find up-to-date information about companies, products and solutions by entering your key word in the search field on this website.

Topics and target group:

* Suppliers and manufacturers Technical consultancies
* Lab managers and staff Researchers
* HR professionals
* Educators and trainers
* Students
* Teachers (Voc Ed, BSc, MSc level)

Specialist information about:

* Lab technologies
* Quality and regulation
* Lab automation
* Lab personel
* Lab management

Industry news

BIOHIT supplies COVID-19 detection kits in the UK
BIOHIT supplies COVID-19 detection kits in the UK
BIOHIT Healthcare Ltd is now distributing test kits for the diagnosis of both current and past COVID-19 infections to help in the fight against coronavirus in the UK. The new product line includes the MutaPLEX Coronavirus kit from ImmundiagnostikAG (IDK) – a real-time RT-PCR assay to screen for infected individuals – and Epitope Diagnostics Inc`s (EDI`s) immunodiagnostic tests for IgM and IgG COVID-19 antibodies, to detect past infections. The IDK MutaPLEX coronavirus screening assay allows the detection of SARS-CoV-2 viral RNA in a variety of biological specimens, especially nasal/throat swabs. This real time RT-PCR kit contains all the reagents, primers and dual-labelled probes required for the amplification and simultaneous differentiation of RNA from SARS-CoV-2 and other betacoronaviruses, as well as house-keeping genes designed to prevent false negative results due to insufficient sample collection or transport problems. EDI`s Novel Coronavirus COVID-19 ELISA
20-04-2020  |  170x  | 
Scaling-up manufacture of nanoparticles for COVID-19 tests
Scaling-up manufacture of nanoparticles for COVID-19 tests
As the COVID-19 pandemic progresses in countries around the globe, there is an urgent need for rapid and reliable point-of-need detection testing. Dolomite Microfluidics and Mologic are working together to accelerate the development and launch of these tests. UK-based company Mologic is a leading developer of rapid response diagnostic tests for diseases such as malaria and Ebola virus disease. Clients include the Bill & Melinda Gates Foundation, where Mologic is leveraging its core technology through its Centre for Advanced Rapid Diagnostics (CARD) to develop the next generation of ultra-sensitive point-of-care diagnostics which are easy to use and inexpensive to manufacture – critical to the success of many global health programmes. Most recently, Mologic has received UK Government funding to develop and manufacture a high sensitivity test for COVID-19 that generates results within minutes – rather than hours or days – without the need for a laboratory or specialist
09-04-2020  |  178x  | 
QIAGEN receives U.S. FDA EUA for QIAstat-Dx test kit syndromic solution integrating detection of SARS-CoV-2 coronavirus
QIAGEN receives U.S. FDA EUA for QIAstat-Dx test kit
syndromic solution integrating detection of SARS-CoV-2 coronavirus QIAGEN today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test for use in diagnosing patients infected with the novel COVID-19 coronavirus. The QIAstat-Dx test kit can differentiate the SARS-CoV-2 coronavirus from 21 other serious respiratory infections in patients who may have similar symptoms in a single testing run of about one hour. It is a multiplexed nucleic acid test that evaluates samples such as nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. The newly approved panel includes assays targeting two genes used to detect the pathogen behind the disease, Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), and is intended for use in laboratories certified under CLIA to perform moderate and high complexity tests. “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test
01-04-2020  |  240x  |   | 

Articles

Integrating labs in the production chain with digital twins and threads
Integrating labs in the production chain with digital twins and threads
Two key expressions of digitalization in Smart Industry are digital threads and digital twins,” Van Barneveld says. Digital threads are the strings of digital information that accom- pany products on their journey through the production chain. Digital information is added at every step along the way, in the manufacture of parts, components and end products. This data can pertain to the quality and origin of raw materials or to the production condition. “Today’s assertive customers demand demonstrable quality, based in part on complete traceability. On top of that, there’s a demand for personalized products and packaging. You want to order green M&Ms only? No problem!” says Van Barneveld.
22-01-2020
Tips for culturing mesenchymal stromal cells
Tips for culturing mesenchymal stromal cells
Ideally, cultured cells have the same characteristics as cells that develop in the patient’s body. But in practice, there are still many obstacles to be overcome in the development of cellular therapies. To begin with, cultured cells need not only to possess the right weapons to attack a tumor, but they must also move in the right direction. That doesn’t always happen, noticed Carlijn Voermans, head of the Cellular Therapy Department at Sanquin, during her research into mesenchymal stromal cell-based the- rapy. Mesenchymal stromal cells are very young cells that mature in the body to become part of cartilage, bone, adipose tissue and other supportive tissues.
20-01-2020
Extra scrumptious tomatoes
Extra scrumptious tomatoes
How is the growth and ripening of fruit regulated? That’s what researcher Ruud de Maagd at Wageningen Plant Research focuses on. The CRISPR-Cas system enables him to edit the genome much more precisely. “Basing our research on the tomato as a model fruit, we use CRISPR-Cas to inhibit certain genes, particularly transcription factors, to determine what their function is. In the past, we did this by means of spontaneous mutants or RNA interference. The dra- wback was that it was difficult to inhibit a gene completely or to inhibit one specific gene if there were several similar genes. CRISPR-Cas works much better and allows us to be far more precise,”
19-02-2020
LiFi: LEDs for data transmission
LiFi: LEDs for data transmission
Is LiFi about to revolutionize data exchange in clean- rooms? LiFi, or light fidelity technology, is like WiFi without the radio waves. Based on Light Emitting Diodes (LEDs), LiFi uses visible UV and Near InfraRed light. The advantage is that light has a much broader spectrum, enabling users to exchange data far more rapidly. This is because LEDs can be switched on and off millions of times per second and this is used to transmit an enormous amount of data. It’s like morse code in a supersonic dimension.
17-02-2020
Show more (11)

Product news

Glasgow Lighthouse Lab facility operational for COVID-19
Glasgow Lighthouse Lab facility operational for COVID-19
The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days. The Lighthouse lab project is funded by the UK Government. The newly operational lab will will test samples from the regional test centres where NHS staff and frontline workers with suspected COVID-19 infections are tested. It is hoped the lab will quickly move towards processing several thousand tests per day, before scaling up further to tens of thousands of tests per day. The Lighthouse Lab in Glasgow is hosted by the University of Glasgow at their Queen Elizabeth University Hospital Campus, and opened in collaboration with the Scottish Government, industry experts
22-04-2020  |  219x  | 
Automation Solutions/Services to Aid Critical Coronavirus Testing Priority Fast Tracking
Automation Solutions/Services to Aid Critical Coronavirus Testing
Priority Fast Tracking Reno, Nevada, USA and Bonaduz, Switzerland (March 17, 2020) – Today, Hamilton Company announces multiple automation-related initiatives to aid healthcare workers and researchers as they battle the coronavirus (COVID-19) pandemic. Two new automated assay ready workstations, based on the Company’s Microlab® STARletliquid handling workstation, facilitate rapid, high-throughput diagnostic and research-based testing of SARS-CoV-2, the coronavirus that causes the novel COVID-19. 1: The MagEx STARlet assay ready workstation enables high-throughput magnetic bead-based RNA extraction of biological samples 2: The PCR Prep STARlet assay ready workstation is pre-configured and qualified to automate high-throughput pre-PCR sample setup using the latest Centers for Disease Control and Prevention (CDC) protocols Both assay ready workstations are designed to work with any provider’s assay chemistry, including those intended for qualitative detection of the coronavirus. Once the
17-03-2020  |  174x  | 
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
SIGN UP FOR OUR NEWSLETTER
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertising